MinervaX attracts $57m Series B

MinervaX, a Danish biotechnology company, has raised $57 million in Series B financing.

MinervaX, a Danish biotechnology company, has raised $57 million in Series B financing. The investors included Sanofi Ventures, Wellington Partners, Adjuvant Capital, Industrifonden, Novo Holdings REPAIR Impact Fund, Sunstone Life Science Ventures and LF Investment.

Source: Press Release